baber/WOPTO huggingface dataset:
Patent JP-H10510294-A (JP)
Title: 脱蛋白血液透析物の使用方法
IPC: A61K35/14
Filed: 1996-05-17
Abstract: (57)【要約】
本発明は幼牛血液から得られた脱蛋白血液透析物を炎症性関節症または非炎症性関節症の治療及び予防の少なくとも一方のために使用する新たな使用方法に関する。この目的を達成するために、血液透析物は５％グルコース液とともに問題の関節内に関節内注射することが好ましい。
Patent JP-2002516031-A (JP)
Title: ヒートシンクを電子部品に取り付けるためのスプリングクリップ
IPC: H05K7/20
Filed: 1998-01-23
Abstract: (57)【要約】
ヒートシンク（３）を電子部品（２）に熱的にかつ機械的に結合するために付勢部材（１０）に機能的に係合する直線的に変位可能なそらせ部材（１１）を有するヒートシンクスプリングクリップ（１４）。そらせ部材（１１）は、付勢部材（１０）が実質的にそらされていない非係合の第１位置と、ヒートシンク（３）を電子部品（２）に熱的にかつ機械的に結合するために、付勢部材（１０）がそらされかつそらせ部材（１１）がヒートシンク（３）と接触的でかつ機能的に係合される第２位置との間を、付勢部材（１０）上でかつ付勢部材（１０）に関して略直線状に移動可能である。そらせ部材（１１）が非係合位置から係合位置に移動されるに伴って、付勢部材（１０）及びそらせ部材（１１）上の相補的エレメントが相互に係合し、更に偏向部材と付勢部材（１０、１１）の一部を相対的に離すように移動させる。付勢部材（１０）がヒートシンク（３）から略離れる１つの方向にそれると、付勢部材（１０）がそらせ部材（１１）を介してヒートシンク（３）とその下に隣接して積み重ねられた電子部品（２）とに略反対方向の圧力を同時に付与する。そらせ部材（１１）は、付勢部材（１０）上に沿って長手方向に略水平方向か、又は代替の実施の態様では付勢部材（１０）の長手に実質的に交差する方向に機能的に移動可能である。
Patent JP-H11507025-A (JP)
Title: バシラス・スリンジエンシス変異体スリンジエンシスからの新しい抗増殖性蛋白質
IPC: C12P21/00
Filed: 1996-05-31
Abstract: (57)【要約】
本発明はＳＤＳ−ＰＡＧＥで判定して分子量が20kDa程度で、ＳＥＱ  ＩＤ  No.１に示されている部分的アミノ酸配列を有しており、腫瘍細胞に対する細胞毒性作用を示すバシラス・スリンジエンシス亜種スリンジエンシスから誘導、単離、精製された蛋白質を提供する。又、治療上有効な量の本発明の組成物を該細胞に投与するステップを含む腫瘍性細胞を措置する方法を提供するものである。
Patent JP-2001525898-A (JP)
IPC: F04D9/04
Filed: 1996-05-29
Abstract: The method uses a centrifugal pump impeller (14) and a vacuum pump rotor (44) placed on the same shaft (49). The gas separated in the centrifugal pump from the material to be pumped is discharged from the centrifugal pump. The discharge uses the vacuum pump and a gas outlet duct (26) located between the two pumps. The gas flow in the gas outlet duct between the two pumps is controlled by changing the cross sectional flow area of the gas outlet duct.
Patent JP-2001516459-A (JP)
Title: 改良された電流感知装置を持つ遮断器
IPC: H02H3/08
Filed: 1999-01-11
Abstract: (57)【要約】
過電流を判定する為の電子式引外し装置を含む形式の遮断器が、引外し装置の電子回路に給電する為の寸法の小さい鉄心入り変流器、及び被保護回路内の電流の流れを感知する大形の磁気抵抗半導体（ＧＭＲ）を有する。
Patent JP-2001513292-A (JP)
Title: メッセージシステム
IPC: H04M3/42
Filed: 1998-02-26
Abstract: (57)【要約】
遠隔通信ネットワークで実行される音声メッセージ送信方法であって：音声メッセージを第１の端末から電話ラインを経由して送信元の第２の端末へ録音する段階と；電話ラインを経由して第２の端末へ接続することを試行する段階と；接続を試行する前記段階が成功すると、前記第２の端末へ前記接続されたメッセージを再生成する段階と；所定の状態において、戻り呼を前記第１の端末に設定することを試行する段階とを含む音声メッセージ伝達方法。
Patent JP-2002515777-A (JP)
Title: 改良された自動吸引機能を有する薬剤注射システム
IPC: A61M5/24
Filed: 1997-05-01
Abstract: (57)【要約】
本発明は、部分的には新規の自動吸引注射器と、薬剤カートリッジと、新規の針アセンブリとを備える改良された薬剤注射システムを提供する。本発明は、歯科医によって局部麻酔薬を投与することを主に目的としているが、医学用および獣医用で同様に十分使用できる。１つの態様において、新規の注射器は、軽量で、持つのが快適で、耐腐食性にされる。他の態様において、注射器の設計のいくつかの新規の変更は、一方の患者の血液から他方の患者の血液への病原菌を伝染させる可能性を減らす。さらに、針アセンブリの設計の革新は、事前殺菌さえすることなしに注射器を安全に使用させ、同時に人間の過失として病原菌を伝染させる可能性を取り除く。
Patent JP-2000510989-A (JP)
Title: Ｅｃｃおよび読出しチヤンネル品質指示器を用いた読出しエラー回復
IPC: H03M13/35
Filed: 1997-03-27
Abstract: (57)【要約】
回復工程に用いられる他の訂正動作と組み合わせてエラー訂正を用いることの適切度を決定するために、読出しチヤンネル品質指示器を用いることによりディスク駆動装置１０のディスク１８からのデータ読出しのシーケンスの中の読出しチヤンネル７０により検出された読出しエラーから回復する装置と方法が開示される。引き出されたデータの中に訂正されなかったエラーが検出される場合、ディスク駆動装置１０は読出し回復ルーチンに入る。この読出し回復ルーチンでは、エラーを除去するために１個または複数個の訂正動作１０２、１２２が行われる。１つのチヤンネル品質指示器は、読出し動作の期問中に回復されサンプリングされたデータ・ビット値の２乗の和として決定されたチヤンネル品質測定値１０８、１２８を有する。このチヤンネル品質測定値が、検出されなかったエラーを含むデータをパスする確率が受容可能なレベルにある（１１０、１３０）とを示す閾値に等しいまたは以下である時、エラー訂正がデータに対して行われる（１１２、１３８）。そうでない場合には、エラー訂正は許容されない（１１８、１４０）。付加的チヤンネル品質指示器は、消去ポインタ１３２を有する。消去ポインタ１３２は、読出しエラーを含むと考えられる特定の組の記号のを識別する。
Patent JP-2001520572-A (JP)
Title: 重力供給水処理装置用フィルタカートリッジ
IPC: C02F1/28
Filed: 1998-03-23
Abstract: (57)【要約】
多孔性粒子フィルタ（２４）が配設されている重力供給水処理装置用フィルタカートリッジ（２０）である。多孔性粒子フィルタ（２４）は、開口上端と、閉口下端と、該開口上端と該閉口下端との間にある側壁とを有している。水はフィルタの側壁を通過する際に処理される。またカートリッジは多孔性粒子フィルタ内に配設された粒状媒質（２６）を含有している。
Patent JP-2001522462-A (JP)
Title: アナログ回路テスタ用のコヒーレンスなスイッチング電源
IPC: G01R31/28
Filed: 1998-04-28
Abstract: (57)【要約】
回路テスタは、波形合成器（１２）で発生したテスト信号で被測定アナログ回路デバイス（ＤＵＴ）（１１）を活動させ、デジタイザ（１４）で結果として生じるＤＵＴ出力信号を周期的にデジタイズしてホストコンピュータ（１８）によって分析される出力データ列を生成してＤＵＴの動作特性を確認する。テスタは、ＤＵＴ出力信号に周期的なノイズスパイクスを引き起こすスイッチング電源（３２）によって電力供給される。テスト結果からノイズスパイクスの影響を取り除くために、スイッチング電源ノイズの周期が、デジタイジング周期とコヒーレンスな関係になされる。そして、デジタイジングのフェーズが調節されて、テスタがＤＵＴ出力信号のノイズスパイクスをデジタイズしないようにする。
Patent JP-2002508754-A (JP)
Title: ｐ３８キナーゼ阻害剤としての置換基を有するピラゾール類
IPC: A61K31/4545
Filed: 1998-05-22
Abstract: (57)【要約】
ｐ３８キナーゼ媒介疾患の治療に利用されるピラゾール誘導体の部類を説明する。特に重要な化合物は、Ｒ 1 、Ｒ 2 、Ｒ 3 及びＲ 4 を明細書の中で説明した式（Ｉ）により定義される。
Patent MX-151352-A (MX)
Inventor: BRULARD MICHEL CHARLES
IPC: B60L7/22
Filed: 1981-10-26
Abstract: A control circuit which permits a direct current motor to operate during traction or during braking in such a manner that energy can be either dissipated or recovered; and, in particular, the invention embodies gradual, continuous, and reversible shifting from one form of braking action to another.
Patent NZ-198063-A (NZ)
Title: Dna transfer vector comprising sequence coding for somatostatin or precursor:transformed microorganism;fusion protein comprising somatostatin or precursor and part of procaryotic protein
Inventor: HOBART P
IPC: C12P21/02
Filed: 1981-08-17
Abstract: Somatostatin precursors are preprosomatostatin-1, prosomatostatin-1, preprosomatostatin-2, prosomatostatin-2 and somatostatin-2. DNA transfer vectors comprise a deoxynucleotide sequence coding for a somatostatin or one of such precursors.
Patent NZ-206063-A (NZ)
Title: Pyrido(2,3-d)pyrimidin-5-one derivatives and pharmaceutical compositions
Inventor: LESHER G Y
IPC: C07D239/42
Filed: 1983-10-26
Abstract: 2-Q-6-Q min -8-R-pyrido[2,3-d]pyrimidin-5(8H)-ones (I), where Q is 4 (or 3)-hydroxyphenyl, 4(or 3)-methoxyphenyl, 4 (or 3)-pyridinyl or 4(or 3)-pyridinyl having one or two lower-alkyl substituents, R min  is hydrogen or alkyl having one to four carbon atoms, Q is hydrogen, amino or nitro, and R is alkyl having from one to four carbon atoms, CH(C2H5)2, (CH2)n = CHCH2 where n is 1 or 2, or Y-Z where Y is alkylene having from one to four carbon atoms and having its connecting linkages on different carbon atoms and Z is hydroxy, OR1 or NR1R2 where R1 and R2 are each methyl or ethyl, or acid-addition salts thereof and there preparation by reacting a 2-Q-4-R min -pyrido[2,3-d]pyrimidin-5(8H)-one of the Formula III (herein) where Q is 4 (or 3)-methoxyphenyl, 4(or 3)-pyridinyl or 4(or 3)-pyridinyl having one or two lower-alkyl substituents or alkali or alkaline earth metal salt thereof with an alkylating agent. Also shown is the cardiotonic use of I where Q is 4(or 3)-hydroxyphenyl, 4(or 3)-pyridinyl or 4(or 3)-pyridinyl having one or two lower-alkyl substituents and Q min  is hydrogen or amino. The novel compounds of Formula III and their preparation are also claimed.
Patent NZ-227244-A (NZ)
Title: Identification marker inserted into end of golf club grip; includes golf ball marker
Inventor: LOCKERMAN SCOTT G
IPC: A63B57/00
Filed: 1988-12-07
Abstract: An identification marker system includes a disclike body portion (16) with a cylindrical anchor means (18) formed on the bottom surface of the body member. An enlarged conical head (20) formed on the bottom of the cylindrical anchor member (18) is forced through a hole (26) in a resilient member to snugly fit the anchor member (18) within the hole. Removal of the marker (10) without permanent disfigurement of the resilient member is therefore prevented. A protective collar (30) is formed on the top surface of the body member and identification indicia (32) are engraved within the space on the top surface of the body member that is protected by the annular collar (30).
Patent NZ-230435-A (NZ)
Title: Method for temporary colouration of textiles using an amine reducible tint
Inventor: HINES JOHN BERY
IPC: D06P5/13
Filed: 1989-08-25
Abstract: A method is provided for temporary coloration of textile materials which comprises applying to said textile materials an amine-reducible tint in an amount sufficient to provide coloration to said textile material, said tint being characterized by the formula:  R{A-[alkeneoxy constituent)nX]m}p wherein RA is the organic, easily reducible dyestuff radical, A is a linking moiety in said organic, easily reducible dyestuff radical selected from the group consisting of -N-, -O-, -S-, or -CO2-, the alkenyl moiety of said alkyleneoxy constituent contains from 2 to about 4 carbon atoms, n is an integer of from 2 to about 300, m is 1 when A is -O-, -S-, -CO2- and 2 when A is -N-, p is an integer of from 1 to 5, and X is a member of the group consisting of -H-, -alkyl, -alkylcarboxylate, or -arylcarboxylate; and contacting said amine-reducible tint with an amine compound in an amount sufficient to reduce said tint whereby said coloration of said textile material is removed.
Patent NZ-231707-A (NZ)
Title: Substituted pyridones and pyridthiones and pharmaceutical compositions thereof
Inventor: FEY PETER
IPC: A61K31/695
Filed: 1989-12-11
Abstract: For inhibiting HMG-CoA reductase and cholesterol synthesis, the novel 2-pyridones and pyrid-2-thiones of the formula  <IMAGE>  in which A is optionally substituted aryl or heterocyclic, B is optionally substituted alkyl, cycloalkyl or aryl, D and E independently are optionally substituted aryl or heterocyclic, H, nitro, cyano, optionally substituted alkyl, alkenyl or imino, amino, alkoxy or acyl, or forms a ring with B, G is O or S, X is -CH2-CH2- or -CH=CH-, and R represents a group of the formula  <IMAGE>  and salts thereof.
Patent NZ-232373-A (NZ)
Title: Injection moulding of metal alloys: metal alloy accumulated in a zone between the extruder and mould prior to entry into the mould
Inventor: BRADLEY NORBERT L
IPC: B29C45/50
Filed: 1990-02-05
Abstract: A method and apparatus for injection molding a metal alloy wherein the alloy is maintained in a thixotropic, semi-solid state in a reciprocating extruder at temperatures above its solidus temperature and below its liquidus temperature in the presence of shearing and then injected as a thixotropic slurry into a mold to form a useful product. Following completion of the injection molding stroke the nozzle of the extruder is sealed by a solidifying a portion of the residue of the alloy remaining in the nozzle.
Patent NZ-237577-A (NZ)
Title: Spaghetti with lobes and grooves
Inventor: GRAVERINI FALIERO
IPC: A23L7/109
Filed: 1991-03-26
Abstract: Spaghetti-type pasta provided with a solid central core 1, forming a single piece with three parallel longitudinal lobes 2 which are equidistant angularly, by 120 DEG , relative to one another and separated by grooves 3. The balance between the shapes and the sizes of the various elements makes it possible to obtain a rapid cooking time with good chewing qualities. <IMAGE>
Patent NZ-239844-A (NZ)
Title: Retinoic acid derivatives and pharmaceutical compositions thereof
Inventor: CARROLL F IVY
IPC: A61P17/00
Filed: 1991-09-18
Abstract: Compounds of the formula <CHEM>  wherein R1 is    CH=CY-C(CH3)=CHX       wherein X and Y are different and each is of the formula <CHEM> wherein R' and R'' independently are H or alkyl of C1-6 and R1 includes all possible geometric isomers. are demonstrated effective in treating inflammation, both topically and internally. The mechanism appears to be the inhibition of phospholipase A2 enzymes.
Patent NZ-242333-A (NZ)
Title: Secure transmission of speech and data: network includes crypto devices
Inventor: NOST JAN PETTER
IPC: H04Q3/58
Filed: 1992-04-13
Abstract: This invention relates to a communication network intended for secure transmission of speech and data, including different types of subscriber terminals (1-4) and switching modules (7-8), where subscriber lines (23-26) connect each subscriber terminal with a switching module and transmission links (19-22) connect each switching module to other switching modules in the network, where transmission links and subscriber lines each carry one or more communication channels, and where the network further comprise crypto devices (13-15) to undertake encryption/decryption or other required protection mechanisms of information transmitted through the network, and where at least one of the crypto devices is constituted by a crypto-pool device having a number of crypto modules (35) which is physically separated from the switching modules (7,8), and which may communicate with the switching modules through standardized interface and communication protocols which makes the device accessible from subscriber terminals, from switching modules or from other network equipment. At least one of the crypto pool devices is a security guard (9 or 10) arranged at the interface between a switching module (7 or 8) and one of its transmission links (19 or 22) such that no impact on the switching module is required. The security guard (9 or 10) includes means stored and managed by a managing device (30) for specifying the criteria for whether a communication channel should be subjected to encryption/decryption or a data packet (message) on a virtual communication channel should be subjected to protection as required. The security guard (9 or 10) includes means stored and managed by the managing device (30) which during installation or a managing procedure are configured by a security manager (17) for monitoring control information on the signalling channel (38 or 39) to detect whether a particular communication channel is to be encrypted/decrypted or a data packet (message) is to be protected as required. <IMAGE>
Patent NZ-243343-A (NZ)
Title: Delayed release dosage forms comprising active agent-containing composition and a polymer composition which imbibes fluid and expands to force active agent composition from capsule
Inventor: JAO FRANK
IPC: A61K9/22
Filed: 1992-06-26
Abstract: A dosage form is disclosed comprising means for delaying the delivery of drug from the dosage form following the administration of the dosage form to a patient in need of drug therapy.
Patent NZ-245146-A (NZ)
Title: Syringe with indicia moveable with plunger and selectably moveable relative to plunger
Inventor: WOODRUFF KEITH F
IPC: A61M5/315
Filed: 1992-11-16
Abstract: A syringe (2) for administering medicines, pharmaceuticals, and other liquid or semi-liquid materials includes a movable scale (18) which is automatically reset to a zero position after a preselected dosage of material has been discharged from the syringe. The scale (18) is adjustable for selecting subsequent dosages to be discharged, which may be the same or different in quantity from the previously discharged dosage. The automatic zero reset feature of the scale (18) enables a user to administer multiple dosages of material from the same syringe, and vary the quantity of each dosage if desired, without the need to make calculations or adjust the scale to compensate for either the quantity of material previously discharged from the syringe or the quantity of material currently remaining in the syringe. The automatic zero reset function is provided by a scale (18) which is movable, together with a slideable stop element (20), relative to a plunger (14) of the syringe (2), and releasably lockable at preselected positions on the plunger (14) corresponding to the quantity of material to next be discharged from the syringe. In further aspects of the invention, the front ends of the plunger and a forward container (4) are tapered for complementary fit, and a storage element (28)is provided on the syringe for removably retaining a cover (10) for a discharge outlet (8) when the syringe is being used. <IMAGE>
Patent NZ-245641-A (NZ)
Title: Collating magazine pages and inserts on rotating, partitioned drum
Inventor: HONEGGER WERNER
IPC: B65H45/101
Filed: 1993-01-08
Abstract: The processing drum (12) which is rotatable about the shaft (14) has advancing means (72) for intermittent advance of the printed products (10) deposited straddled on the supports (24). These advancing means (72) execute a working stroke in the upper region of the circular path around the shaft (14) and in the lower region a return stroke. The processing drum (12) is embraced from below by a pulling element (46) on which holding members (44) are arranged at the spacing (A) of the supports (24) in order to prevent the printed products (10) falling down as they pass through the lower part of the circular path and at the same time to support the elongated processing drum (12). <IMAGE>
Patent NZ-248281-A (NZ)
Title: 3-(=ch-oh)benzofuranone; derivatives and preparatory process
Inventor: JONES JOHN DAVID
IPC: C07D311/12
Filed: 1991-11-01
Abstract: Processes for the preparation of compounds (X), (XI) and (XII): <CHEM>   <CHEM>   <CHEM> where M is an alkali metal or alkaline earth metal and n is 1 or 2, and for obtaining compound (X) in a substantially pure form. These compounds are useful intermediates in the manufacture of fungicides.
Patent NZ-292163-A (NZ)
Title: Recombinant production of arabinoxylan degrading enzyme
Inventor: VAN DER WOUW MONIQUE JOSINA AN
IPC: C12N15/113
Filed: 1995-08-28
Abstract: An arabinoxylan-degrading enzyme from Aspergillus is provided. The enzyme is active in the degradation of water-insoluble solids obtained from maize. The enzyme can be used in the preparation of animal feed compositions, human food or in industrial processes.
Patent NZ-292729-A (NZ)
Title: Water-soluble ionene polymers incorporating biologically-active compound as an anion, intermediates, pesticidal and fertiliser compositions and medicaments
Inventor: WARD JAMES A
IPC: A61K47/48
Filed: 1995-08-30
Abstract: Ionene polymers having biologically-active organic and/or inorganic anions are described. Methods to prepare the ionene polymers, compositions containing them and their methods of use are also described.
Patent NZ-308966-A (NZ)
Title: Process for splitting residues by wet cleaning, crushing and separating to obtain secondary raw materials in three fractions for use as raw materials and secondary fuels
Inventor: FELBER WALTER
IPC: B09B3/00
Filed: 1996-06-07
Abstract: In this process for reducing so far unused residues from tailings, soiled plastics from "yellow waste", "strainings" from sewage plants, rubbish from dumps and sand residues to obtain and recycle secondary raw materials, the wastes are subjected to a repeated cycle of wet and dry sieving, separation, sorting and classification. The clean secondary raw materials obtained are preferably conditioned in stages in an aerobic environment and, except for difficult materials, taken directly to biological, material or raw material processing plants. Conditioning the secondary raw materials also permits long intermediate storage owing to the slight degree of rotting and stink. The low investment costs make it possible to set up small plants for regional waste economies while still offering economic advantages over competing technologies. The system can be operated without subsequent deposition or mass incineration for the residue processing involving about a sixth of the partial mass flow rate of mixed plastics, composites and other materials. Residues can be made into building materials. Fine "strainings" are not given any prior dry mechanical treatment.
Patent NZ-311120-A (NZ)
Title: Vaccine containing the omp26 antigen from haemophilus influenzae
Inventor: KYD JENNELLE
IPC: A61P31/04
Filed: 1996-06-27
Abstract: A novel antigenic protein derived from the outer membrane of H. influenzae is provided. DNA sequences encoding such a protein are also provided as are vaccines comprising the protein and methods of immunising a subject against H. influenzae infection. The invention also includes methods for the prophylaxis or treatment of rerspiratory tract infections or otitis media, as well as methods for the detection of H. influenzae, and kits for use in such methods.
Patent NZ-311208-A (NZ)
Title: Composition comprising an active agent dissolved in a glass-forming carrier comprising a glass-forming substance containing a plasticizer, composition is liquid or jelly-like below 50 degrees
Inventor: LINDAHL AKE
IPC: A61K31/405
Filed: 1996-06-19
Abstract: PCT No. PCT/SE96/00806 Sec. 371 Date Dec. 17, 1997 Sec. 102(e) Date Dec. 17, 1997 PCT Filed Jun. 19, 1996 PCT Pub. No. WO97/00670 PCT Pub. Date Jan. 9, 1997A biologically active composition comprising a solution of an active agent dissolved in a glass-forming carrier, which carrier comprises a glass-forming substance (A) containing a plasticizer (B), the amount of plasticizer preferably being selected so that the composition has a non-solid consistency. The composition can be prepared by dissolving the active agent in a melted mixture of the glass-forming substance and the plasticizer at a temperature below the decomposition temperature of said active agent. Use of the glass-forming carrier for dissolving a biologically active agent.
Patent NZ-331384-A (NZ)
Title: Method for preparing a mortar using inorganic grains of less than 500 um
Inventor: COURAGE ANTONIUS JOHANNES FRAN
IPC: C04B28/02
Filed: 1997-02-13
Abstract: Method for preparing a concrete mortar which contains a fraction of inorganic grains having a diameter <500  mu m, wherein the fraction containing the inorganic grains is added in the form of a granular material which contains the inorganic grains which, with the aid of a water-soluble polymer, are bound so as to form the granular material. As a result, a homogeneous mortar is obtained.
Patent NZ-331523-A (NZ)
Title: 7-phenyl-1-benzoyl-1,4-diazepene derivatives, preparations and intermediates containing these and methods for preparing them, for treatment of neurokinins that cause pain
Inventor: DAVID SAMUEL
IPC: A61P1/00
Filed: 1998-08-24
Abstract: 7-phenyl-1,4-diazepane derivatives of the formula 1 R1 is H or lower alkyl R2 is H, lower alkyl, lower alkoxy, halogen or CF3 R3 is H, lower alkyl, lower alkoxy, halogen or CF3 R2 and R3 together are alkylenedioxy with 1-2-carbon atoms, bonded to adjacent carbon atoms of the phenyl ring R4 is H, lower alkyl, lower alkoxy, halogen or CF3 R5 is lower alkyl, H, lower alkoxy, halogen or CF3 R4 and R5 together are alkylenedioxy with 1-2-carbon atoms, bonded to adjacent carbon atoms of the phenyl ring R6 is lower alkyl, halogen, or CF3 R7 is lower alkyl, halogen or CF3 A is a -(CH2)n- group where n = 1-3 or -NH-(CH2)m- where m is 2 -3 B is an alkylene chain with 1-3-carbon atoms optionally substituted by lower alkyl Or a physiologically compatible acid addition salt thereof. Also claimed is a process for preparation of these compounds for treating prophylaxis of a pathological condition induced by neurokinin.
Patent NZ-332355-A (NZ)
Title: Footwear comprising a laminated inner sole strobel stitched to a upper shoe
Inventor: HOOD ROBIN J
IPC: A43B9/02
Filed: 1998-10-16
Abstract: A shoe or boot insert including at least a shoe upper, an insole and an outer sole, wherein the insole is integrally connected to a lower edge of the shoe upper by strobeling.  The shoe insert includes a composite body formed by the conjunction of two layers of pre-selected insole layer materials and where the stitching integrally connects the insole and the shoe upper, penetrating all layers of the insole.
Patent NZ-333536-A (NZ)
Title: Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles, and use as antitumour agents
Inventor: SAULNIER MARK GEORGE
IPC: A61P35/00
Filed: 1997-08-21
Abstract: The present invention concerns novel amino sugar and related sugar derivatives of indolopyrrolocarbazoles, their use as antitumor agents, and pharmaceutical formulations.
Patent NZ-333650-A (NZ)
Title: Analogs of cationic proteins like NT-3 (neurotrophin-3) and BDNF (brain derived neurotrophic factor) that are circulated more readily due to a lower isoelectric point and a lower protein charge relative to the native protein
Inventor: BOONE THOMAS C
IPC: A61K38/00
Filed: 1997-07-17
Abstract: The specification teaches that the in vivo circulating life and/or absorption of cationic therapeutic proteins, including but not limited to basic proteins such as NT-3 and BDNF, can be increased by generating analogs that have a lower isoelectric point and, preferably, also a lower protein charge relative to the protein of native sequence.
Patent NZ-335647-A (NZ)
Title: Spray dispenser rechargeable by inserts within spray container
Inventor: KLIMA WILLIAM L
IPC: B67D7/74
Filed: 1995-07-25
Abstract: Insert 20 has separated compartments 22, 24, 26 which are each able to be punctured by dip tube 18 of head 12. Other embodiments are disclosed.